Sleep is one of the most fundamental biological needs, as essential to survival as food and water. Yet for the millions of Americans struggling with substance use disorders, quality sleep is often the first casualty and the last thing to recover. The relationship between addiction and sleep disorders is bidirectional, deeply intertwined, and profoundly consequential: substance use disrupts sleep architecture, and sleep deprivation increases vulnerability to substance use, creating a vicious cycle that can undermine even the most committed recovery efforts.
Research from the National Institutes of Health (NIH) indicates that between 25 and 72 percent of people in addiction treatment report significant sleep disturbances, compared to approximately 10 to 15 percent of the general population. These are not minor inconveniences. Sleep disorders in recovery are clinically significant conditions that impair cognitive function, emotional regulation, physical health, and decision-making capacity, all of which are essential for maintaining sobriety. Perhaps most alarmingly, research has consistently identified sleep disturbance as one of the strongest predictors of relapse, with some studies finding that insomnia in early recovery increases relapse risk by up to five times.
Despite the critical importance of sleep in recovery, it remains one of the most underaddressed aspects of addiction treatment. Many treatment programs focus primarily on the psychological, behavioral, and social dimensions of addiction while giving inadequate attention to the biological foundation of sleep. This article explores how different substances disrupt sleep architecture, the specific sleep disorders that commonly emerge during recovery, evidence-based treatments for sleep problems in the context of addiction, and practical sleep hygiene strategies for people rebuilding their lives in recovery.
Understanding Sleep Architecture
To understand how substances disrupt sleep, it is helpful to understand what healthy sleep looks like. Normal sleep cycles through several stages in roughly 90-minute cycles throughout the night. Non-rapid eye movement (NREM) sleep consists of three stages: N1 (light sleep, the transition from wakefulness), N2 (true sleep onset, characterized by sleep spindles and K-complexes that play a role in memory consolidation), and N3 (deep sleep, also called slow-wave sleep, which is critical for physical restoration, immune function, and growth hormone release). Rapid eye movement (REM) sleep is the stage associated with vivid dreaming and is essential for emotional processing, memory consolidation, and cognitive function.
A healthy night of sleep involves four to six complete cycles, with the proportion of deep sleep being greatest in the first half of the night and REM sleep increasing toward morning. Disruption of this architecture, whether through reduced total sleep time, fragmented sleep, suppression of specific stages, or alteration of the normal cycling pattern, produces measurable impairments in physical health, cognitive function, emotional regulation, and overall quality of life.
How Different Substances Disrupt Sleep
Alcohol
Alcohol is perhaps the most widely used sleep aid in the world, with surveys indicating that approximately 20 percent of Americans use alcohol to help them fall asleep. While alcohol does indeed reduce sleep onset latency (the time it takes to fall asleep) and increases deep sleep in the first half of the night, it profoundly disrupts sleep in the second half. As alcohol is metabolized, a rebound effect occurs that fragments sleep, reduces REM sleep, increases awakenings, and produces lighter, less restorative sleep. Chronic alcohol use leads to tolerance to the sedative effects, requiring progressively more alcohol to achieve the same sleep-inducing effect, while the sleep-disrupting effects worsen.
During alcohol withdrawal, sleep disturbances can be severe and long-lasting. Insomnia, vivid nightmares, and fragmented sleep are among the earliest and most persistent withdrawal symptoms. Research has shown that sleep abnormalities, particularly reduced slow-wave sleep and disrupted REM regulation, can persist for months to years after cessation of alcohol use, well beyond the resolution of other withdrawal symptoms. This persistent sleep disruption is a major risk factor for relapse, as exhausted individuals in recovery may be tempted to return to alcohol for its sedative effects.
Opioids
Opioids disrupt sleep through multiple mechanisms. They suppress REM sleep and deep sleep, increase the number of transitions between sleep stages (producing fragmented, non-restorative sleep), and cause central sleep apnea, a condition in which the brain intermittently fails to send the signal to breathe during sleep. Research has found that up to 75 percent of patients on chronic opioid therapy have sleep-disordered breathing, and central sleep apnea associated with opioid use can be severe enough to be life-threatening.
During opioid withdrawal, insomnia is one of the most distressing and persistent symptoms. The insomnia of opioid withdrawal is often accompanied by restless legs syndrome, muscle aches, and anxiety, creating a perfect storm of sleep disruption that can persist for weeks to months. For patients on Medication-Assisted Treatment (MAT), methadone and buprenorphine can also affect sleep, though generally to a lesser degree than illicit opioids.
Stimulants
Cocaine, methamphetamine, and prescription stimulants directly interfere with sleep by increasing alertness, suppressing the drive to sleep, and disrupting circadian rhythm regulation. Chronic stimulant use often produces a pattern of extended wakefulness (sometimes lasting days) followed by crash periods of excessive sleep, fundamentally destabilizing the body's circadian clock. During active use, stimulant users experience dramatically reduced total sleep time, suppression of REM sleep, and poor sleep quality even when sleep does occur.
During stimulant withdrawal, a period of hypersomnia (excessive sleeping) typically occurs as the body attempts to recover from prolonged sleep deprivation. This is followed by a period of disturbed sleep that can include insomnia, vivid dreams, and an inability to maintain normal sleep-wake schedules. The circadian disruption caused by chronic stimulant use can take weeks to months to normalize.
Cannabis
Cannabis has complex effects on sleep that depend on the strain, dosage, frequency of use, and individual factors. THC reduces sleep onset latency and may increase deep sleep at lower doses, but it suppresses REM sleep, which is essential for emotional processing and memory consolidation. Regular cannabis users often report using the substance specifically as a sleep aid, but chronic use leads to tolerance to the sleep-promoting effects and dependence on cannabis for sleep initiation.
Cannabis withdrawal produces some of the most vivid and disturbing dream experiences of any substance withdrawal, a phenomenon attributed to REM rebound, the brain's attempt to recover the REM sleep that was suppressed during active use. Insomnia during cannabis withdrawal can be intense and is one of the most common triggers for relapse, as users know that cannabis will immediately resolve their sleep difficulties.
Benzodiazepines and Sedatives
Benzodiazepines, including diazepam, alprazolam, and clonazepam, and non-benzodiazepine sleep aids like zolpidem are among the most commonly prescribed medications for insomnia. While they are effective at reducing sleep onset latency, they significantly alter sleep architecture by suppressing deep sleep and, to varying degrees, REM sleep. This means that while the person may sleep longer, the quality and restorative value of that sleep is diminished.
Withdrawal from benzodiazepines produces some of the most severe and prolonged insomnia of any substance. Rebound insomnia, often worse than the original sleep difficulty, can persist for weeks to months and is a primary driver of relapse. The protracted withdrawal syndrome associated with benzodiazepines can include sleep disturbances lasting six to twelve months or longer, requiring careful medical management and behavioral interventions.
Common Sleep Disorders in Recovery
People in addiction recovery are at elevated risk for several specific sleep disorders that may require targeted treatment.
Insomnia disorder, characterized by difficulty falling asleep, staying asleep, or waking too early, with associated daytime impairment, is the most common sleep complaint in recovery. Studies suggest that 36 to 72 percent of people entering addiction treatment meet criteria for insomnia disorder. Unlike the temporary insomnia experienced during acute withdrawal, chronic insomnia in recovery may persist for months to years if not specifically addressed.
Sleep apnea, both obstructive (caused by physical airway obstruction) and central (caused by failure of the brain's respiratory drive), is significantly more prevalent in people with substance use disorders than in the general population. Obesity, which is common in recovery from alcohol and opioid use disorders, increases the risk of obstructive sleep apnea. As noted earlier, opioid use is specifically associated with central sleep apnea. Untreated sleep apnea produces chronic sleep deprivation even when the person appears to be sleeping adequately, and is associated with increased cardiovascular risk, cognitive impairment, and daytime sleepiness.
Circadian rhythm disorders are particularly common in people recovering from stimulant use disorders, as chronic stimulant use fundamentally disrupts the body's internal clock. Delayed sleep phase disorder, in which the person's natural sleep-wake cycle is shifted later than desired, is frequently observed and can persist long after stimulant cessation. Irregular sleep-wake rhythm disorder, characterized by the absence of a consistent sleep-wake pattern, may also occur.
Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) are frequently reported during opioid and alcohol withdrawal and can persist into recovery. These conditions involve uncomfortable sensations in the legs (RLS) or involuntary leg movements during sleep (PLMD) that disrupt sleep onset and maintenance.
Why Sleep Matters So Much for Recovery
The connection between sleep and relapse is not merely correlational but involves specific neurobiological mechanisms that directly affect a person's ability to maintain sobriety. Sleep deprivation impairs the prefrontal cortex, the brain region responsible for executive functions including impulse control, decision-making, and emotional regulation. These are precisely the capacities that people in recovery most need to resist cravings and make healthy choices. Research using brain imaging has shown that even one night of sleep deprivation produces changes in brain activity that are remarkably similar to the changes seen in active addiction, including reduced prefrontal cortex activity and increased amygdala reactivity.
Sleep deprivation also dysregulates the hypothalamic-pituitary-adrenal (HPA) axis, the body's primary stress response system. Chronic sleep disruption produces elevated cortisol levels, increased stress reactivity, and reduced stress tolerance, creating a state of chronic physiological stress that is a well-established trigger for substance use. People who are sleep-deprived are more reactive to stress, less able to cope with negative emotions, and more likely to engage in impulsive behaviors, including substance use.
Furthermore, sleep plays a critical role in the consolidation of new learning and the formation of new neural pathways. The coping skills, cognitive restructuring, and behavioral changes learned in treatment require adequate sleep to be consolidated into long-term memory and integrated into habitual behavior. Without sufficient sleep, the therapeutic gains made during the day may be partially lost, slowing the learning process that is central to recovery.
Evidence-Based Treatments for Sleep Disorders in Recovery
Cognitive Behavioral Therapy for Insomnia (CBT-I)
CBT-I is considered the first-line treatment for chronic insomnia by the American Academy of Sleep Medicine and the American College of Physicians, and it is particularly well-suited for people in addiction recovery because it avoids the use of potentially addictive sleep medications. CBT-I is a structured, typically six to eight session program that addresses the cognitive and behavioral factors that perpetuate insomnia.
The core components of CBT-I include sleep restriction therapy, which involves temporarily limiting time in bed to match actual sleep time, thereby increasing sleep drive and consolidating sleep. As sleep efficiency improves, time in bed is gradually extended. Stimulus control therapy reestablishes the association between the bed and sleep by eliminating sleep-incompatible activities in bed (such as watching television, scrolling through phones, or lying awake worrying) and instructing patients to leave the bed if they cannot sleep within approximately 20 minutes. Cognitive restructuring addresses the anxious, catastrophic thoughts about sleep that perpetuate insomnia, such as "If I do not sleep tonight, I will not be able to function tomorrow." Relaxation training, including progressive muscle relaxation and mindfulness techniques, reduces the physiological arousal that interferes with sleep onset.
Research has demonstrated that CBT-I is as effective as sleep medications in the short term and significantly more effective in the long term, with benefits that persist well after treatment ends. For people in addiction recovery, CBT-I has the additional advantage of building self-efficacy around sleep, reinforcing the recovery principle that challenges can be managed through skills and effort rather than through substances.
Sleep Hygiene Optimization
While sleep hygiene education alone is not sufficient to treat clinical insomnia, optimizing sleep habits is an important component of any sleep improvement program. Key sleep hygiene principles for people in recovery include maintaining a consistent sleep and wake schedule, including on weekends, to support circadian rhythm stability. Creating a sleep-conducive environment that is dark, quiet, cool (around 65 to 68 degrees Fahrenheit), and reserved primarily for sleep. Avoiding caffeine after noon, as its half-life of five to seven hours means that afternoon caffeine can significantly disrupt nighttime sleep. Limiting screen exposure in the hour before bed, as the blue light emitted by phones, tablets, and computers suppresses melatonin production and delays sleep onset.
Establishing a consistent pre-sleep routine that signals to the body that sleep is approaching, such as taking a warm shower, reading, or practicing relaxation exercises. Getting regular physical exercise, which has been shown to improve sleep quality, but avoiding vigorous exercise within three to four hours of bedtime. Avoiding naps longer than 20 to 30 minutes or naps taken after mid-afternoon, which can reduce nighttime sleep drive. Managing fluid intake to reduce nighttime awakenings for urination.
Medications for Sleep in Recovery: A Careful Balance
Pharmacological treatment of sleep disorders in people with substance use histories requires careful consideration of abuse potential and the principle that long-term recovery is best supported by non-pharmacological strategies. Benzodiazepines and Z-drugs (zolpidem, zaleplon, eszopiclone) are generally avoided in people with substance use disorders due to their abuse potential and the risk of cross-addiction.
Several medications with lower abuse potential may be appropriate in specific situations, always under close medical supervision. Trazodone, a serotonin modulator originally developed as an antidepressant, is commonly used off-label for insomnia in recovery populations and has a low abuse potential. Hydroxyzine, an antihistamine with anxiolytic properties, can be helpful for sleep-onset insomnia associated with anxiety. Gabapentin, while requiring caution due to emerging reports of misuse potential, can be useful for insomnia associated with alcohol withdrawal and restless legs syndrome. Melatonin and melatonin receptor agonists (ramelteon) have minimal abuse potential and can help with circadian rhythm disruption. Suvorexant and lemborexant, orexin receptor antagonists, represent a newer class of sleep medications that may have lower abuse potential than traditional hypnotics, though more research is needed in addiction populations.
Practical Sleep Strategies for People in Recovery
Beyond formal treatment, several practical strategies can help people in recovery improve their sleep. Developing a wind-down routine that replaces substance use as the transition from wakefulness to sleep is essential. Many people in active addiction relied on their substance of choice to signal the end of the day and the beginning of rest. Finding alternative rituals, such as herbal tea, journaling, gentle stretching, meditation, or reading, fills this transitional space with healthy activities.
Managing the anxiety and racing thoughts that commonly accompany early recovery insomnia can be aided by keeping a journal or worry list by the bed. Writing down concerns and to-do items before attempting sleep can help externalize anxious thoughts and reduce rumination. Some people find that guided sleep meditations or progressive muscle relaxation recordings provide a helpful focus for the mind during the sleep-onset period.
Physical exercise is one of the most effective non-pharmacological interventions for improving sleep quality. Regular moderate-intensity exercise has been shown to reduce sleep onset latency, increase total sleep time, and improve sleep quality in both clinical and non-clinical populations. For people in recovery, exercise offers the additional benefits of reducing cravings, improving mood, and providing a healthy source of the endorphins that substances once provided.
Addressing co-occurring conditions that affect sleep is crucial. Depression, anxiety, PTSD, and chronic pain are all common in recovery and all have significant effects on sleep. Integrated treatment that addresses these conditions alongside the substance use disorder and sleep problems produces the best outcomes. Many people find that as their mental health improves through treatment, their sleep improves as well, creating a positive cycle that reinforces recovery.
Struggling with Sleep in Recovery?
Quality sleep is essential for lasting recovery. Call (855) 641-2390 to find a treatment program that addresses both addiction and sleep disorders. Available 24/7.
Call Now: (855) 641-2390